The Headline Figures In the 48-week trial, participants receiving the highest dose of retatrutide (12 mg) lost an average of 24.2% of their body weight
Stops Glucagon : GLP-1 inhibits glucagon, a hormone that raises blood sugar, helping to prevent spikes
The evidence base includes STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Peyronies disease has the potential to be treated conservatively with good results
Ipamorelin has small amino acid chains and is available in different forms
A peer-reviewed study found that GHRP-2 reduced expression of Cd86, Nos2, and tnfa (all with statistical significance at P less than 0.01), suggesting inhibited M1 macrophage polarization